If Dr. LL made a appearance on Jim Cramer's Mad Money, there would be a intra-day spike, followed by a intra-day collapse of the SP. Outside of a partnership, approval is the only lasting solution for the common shares on NW Bio. That is forth-coming, I am about 90% sure of. Just will take a bit more time.
Biotech investing will chew you up and spit you out if you dont have the proper intestinal fortitude to see it through. Retail investors often get lured into Biotech for the big gains without realizing:
1) What they are investing in
2) how long it takes to reap the the fruits of the Company's labor, which is measured in years and years, not months and months.
I am willing to bet 90% of investors in NW thought they would be rich by now. Its never than easy in Biotech, ever.
Luckily for NW, the beginning of the end is near(ing). I am almost certain, based on people I know within the industry and who have experience in such matters (Biotech M&A), that NW will be acquired shortly after MHRA approval. These same people have told me approval is damn-near 100%. Time will tell if they are correct but I tend to believe them based of their experience and personally as I know his industry structure works. One things for sure = NW isnt posturing like a "go-it-alone" Company...aging Management Team, no new hires,etc...not what you would expect a Company that is expecting to expand based off demand of a newly approved Cancer treatment that will be in high demand. This technology is best used/exploited with a much more experienced Management Team that knows the ins and outs of this industry. NW is clearly challenged in this area, as are most small pre-rev biotechs. This technology needs and will be transferred..... it will be best for all involved = patients, caregivers and us investors. Investors talking about $500B MC are just fooling themselves and to put it nicely, delusional. NW wont exist as a Company by the time DCVax makes that kind of market penetration.
AI
Market Data 
Markets 
